Definitive Healthcare Corp. (DH)
Market Cap | 647.55M |
Revenue (ttm) | 255.85M |
Net Income (ttm) | -364.28M |
Shares Out | 154.92M |
EPS (ttm) | -3.11 |
PE Ratio | n/a |
Forward PE | 14.22 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 553,257 |
Open | 4.070 |
Previous Close | 4.140 |
Day's Range | 4.065 - 4.320 |
52-Week Range | 3.190 - 10.620 |
Beta | 1.40 |
Analysts | Hold |
Price Target | 6.15 (+47.13%) |
Earnings Date | Nov 7, 2024 |
About DH
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company’s platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician... [Read more]
Financial Performance
In 2023, Definitive Healthcare's revenue was $251.42 million, an increase of 12.92% compared to the previous year's $222.65 million. Losses were -$202.39 million, 2702.4% more than in 2022.
Financial StatementsAnalyst Forecast
According to 11 analysts, the average rating for DH stock is "Hold." The 12-month stock price forecast is $6.15, which is an increase of 47.13% from the latest price.
News
Definitive Healthcare Corp. (DH)) Q3 2024 Earnings Call Transcript
Definitive Healthcare Corp. (NASDAQ:DH) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Matt Ruderman - Investor Relations Kevin Coop - Chief Executive Officer Richa...
Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2024
Third quarter revenue exceeded guidance, and the Company announced a $100 million repurchase authorization Third quarter revenue exceeded guidance, and the Company announced a $100 million repurchase ...
Definitive Healthcare launches Monocl Conferences to improve conference planning and participation for biopharma and medtech organizations
Monocl Conferences equips life science organizations with an intuitive solution to enhance conference planning and KOL engagement Monocl Conferences equips life science organizations with an intuitive...
Definitive Healthcare launches predictive analytics solution that empowers healthcare organizations to prepare and plan for future market conditions
Market Forecast equips providers with three, five, and 10-year market trend projections to strengthen strategic planning around future demand and growth opportunities Market Forecast equips providers ...
Irenic Capital Management LP's Strategic Acquisition in Definitive Healthcare Corp
On September 30, 2024, Irenic Capital Management LP (Trades, Portfolio) made a significant addition to its investment portfolio by acquiring 6,413,185 shares of Definitive Healthcare Corp (DH, Financi...
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Definitive Healthcare Corp. (DH) on Behalf of Investors
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Definitive Health...
Definitive Healthcare to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
FRAMINGHAM, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that ...
The Law Offices of Frank R. Cruz Announces Investigation of Definitive Healthcare Corp. (DH) on Behalf of Investors
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (NASDAQ: DH) on behalf of investors ...
Definitive Healthcare launches powerful consumer analytics and activation solution to more industries with Population Intelligence expansion
Population Intelligence empowers businesses to improve marketing campaigns and digital advertising performance with combined clinical and consumer insights Population Intelligence empowers businesses ...
Definitive Healthcare: Poor Near-Term Outlook, But New CEO May Change Things
DH remains a hold rating due to its poor near-term outlook and recent results. 2Q24 results show decelerating growth, client count decline, and an elongated sales cycle. New CEO Kevin Coop could be a ...
Definitive Healthcare Corp. (DH) Q2 2024 Earnings Call Transcript
Definitive Healthcare Corp. (NASDAQ:DH) Q2 2024 Earnings Conference Call August 5, 2024 5:00 PM ET Company Participants Matt Ruderman - Investor Relations Kevin Coop - Chief Executive Officer Rick Bo...
Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2024
FRAMINGHAM, Mass., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, toda...
Definitive Healthcare Announces Timing of Its Second Quarter 2024 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that ...
Baker Tilly and Definitive Healthcare enhance life sciences compliance
CHICAGO--(BUSINESS WIRE)--Leading advisory, tax and assurance firm Baker Tilly announces its collaboration with Definitive Healthcare to streamline fair market value (FMV) and key opinion leader (KOL)...
Definitive Healthcare launches redesigned mobile app to enhance access to healthcare commercial intelligence
DH View Suite gives sales and marketing teams instant access to critical intelligence right from their mobile devices DH View Suite gives sales and marketing teams instant access to critical intellige...
Definitive Healthcare Corp. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FRAMINGHAM, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that Definitive Healthcare's Board of...
Definitive Healthcare Wins 2024 Databricks Healthcare and Life Sciences Partner of the Year Award
Empowering healthcare and life science organizations with faster insights through seamless data sharing Empowering healthcare and life science organizations with faster insights through seamless data ...
Definitive Healthcare Publishes 2023 Sustainability Report
FRAMINGHAM, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today released its 2023 sustainability report.
Definitive Healthcare to Present at the Stifel 2024 Cross Sector Insight Conference
FRAMINGHAM, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that i...
Definitive Healthcare Appoints Kevin Coop as CEO for Next Phase of Company's Growth
Mr. Coop brings more than 30 years of Operations, Product and Revenue Expertise Mr. Coop brings more than 30 years of Operations, Product and Revenue Expertise
Definitive Healthcare to Present at the 52nd Annual J.P. Morgan Global Technology, Media and Communications Conference
FRAMINGHAM, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that i...
Definitive Healthcare Corp. (DH) Q1 2024 Earnings Call Transcript
Definitive Healthcare Corp. (NASDAQ:DH) Q1 2024 Earnings Conference Call May 7, 2024 5:00 PM ET Company Participants Matthew Ruderman - Investor Relations Jason Krantz - Founder, Executive Chairman a...
Definitive Healthcare Announces Timing of Its First Quarter 2024 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that...
VML and Definitive Healthcare announce partnership to transform key opinion leader management
Partnership offers solution to streamline engagement between pharmaceutical companies and KOLs to help increase the value of the clinical collaborations and conversations Partnership offers solution t...
Definitive Healthcare: Reiterate Buy Rating As I Expect Growth To Recover In FY25
Definitive Healthcare stock is recommended as a buy due to strong long-term growth prospects and potential for margin expansion. Recent results show revenue growth in line with estimates and improved ...